Cargando…
Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis
BACKGROUND: Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD). We herein compare health outcomes associated with carvedilol or bisoprolol use, the most commonly prescribed BBs in these patients. METH...
Autores principales: | Wu, Ping-Hsun, Lin, Yi-Ting, Liu, Jia-Sin, Tsai, Yi-Chun, Kuo, Mei-Chuan, Chiu, Yi-Wen, Hwang, Shang-Jyh, Carrero, Juan-Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986334/ https://www.ncbi.nlm.nih.gov/pubmed/33779636 http://dx.doi.org/10.1093/ckj/sfaa248 |
Ejemplares similares
-
Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis
por: Lin, Yi-Ting, et al.
Publicado: (2019) -
COVID-19 Vaccines in Patients with Maintenance Hemodialysis
por: Yen, Cheng-Chieh, et al.
Publicado: (2021) -
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016) -
Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach
por: Wu, Ping-Hsun, et al.
Publicado: (2019) -
High Cost and Low Survival Rate in High Comorbidity Incident Elderly Hemodialysis Patients
por: Lin, Yi-Ting, et al.
Publicado: (2013)